Page last updated: 2024-08-23

pirfenidone and Emphysema

pirfenidone has been researched along with Emphysema in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuma, A; Gemma, A; Inomata, M; Miura, Y; Nei, T; Saito, T; Saito, Y; Takoi, H; Tanaka, T; Yatagai, Y1
De Jong, PA; De Raedt, N; Dupont, LJ; Gheysens, O; Ruttens, D; Van Raemdonck, DE; Vanaudenaerde, BM; Vandermeulen, E; Verleden, GM; Verleden, SE; Vos, R; Yserbyt, J1

Other Studies

2 other study(ies) available for pirfenidone and Emphysema

ArticleYear
Reduced incidence of lung cancer in patients with idiopathic pulmonary fibrosis treated with pirfenidone.
    Respiratory investigation, 2018, Volume: 56, Issue:1

    Topics: Aged; Antineoplastic Agents; Emphysema; Female; Humans; Idiopathic Pulmonary Fibrosis; Incidence; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Pyridones; Retrospective Studies; Risk; Vital Capacity

2018
Pirfenidone: a potential new therapy for restrictive allograft syndrome?
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013, Volume: 13, Issue:11

    Topics: Allografts; Anti-Inflammatory Agents, Non-Steroidal; Emphysema; Fluorodeoxyglucose F18; Humans; Lung Transplantation; Male; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Pulmonary Fibrosis; Pyridones; Radiopharmaceuticals; Syndrome; Tumor Necrosis Factor-alpha

2013